carbon monoxide has been researched along with Cystic Fibrosis in 35 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Oxidative stress and hypoxia, which may occur in cystic fibrosis patients (CF) at rest and may be worsened by exercise, induce the expression of heme oxygenase (HO)-1, resulting in increased carbon monoxide (CO) formation." | 9.09 | Exhaled carbon monoxide concentration increases after exercise in children with cystic fibrosis. ( Apor, P; Borka, P; Horváth, I; Kollai, M, 1999) |
| "To estimate the value of diffusing capacity for carbon monoxide (T(LCO)) in patients with cystic fibrosis and to evaluate its ability to predict arterial desaturation during exercise." | 7.72 | [Diffusing capacity for carbon monoxide (T(LCO)) and oxygen saturation during exercise in patients with cystic fibrosis]. ( Belleguic, C; Chemery, L; Dabadie, A; Dassonville, J; Deneuville, E; Desrues, B; Fekete, K; Guillot, S; Roussey, M, 2004) |
| "Exhaled nitric oxide (eNO) and carbon monoxide (eCO) concentrations are elevated in inflammatory airway diseases like asthma and have been investigated as potential diagnostic markers." | 7.72 | Exhaled carbon monoxide is not flow dependent in children with cystic fibrosis and asthma. ( Beck-Ripp, J; Griese, M; Latzin, P, 2004) |
| "Increased levels of exhaled carbon monoxide (fractional concentration of CO in expired gas (FE,CO)), measured with an electrochemical sensor, have been reported in patients with inflammatory airway disorders, such as asthma, rhinitis and cystic fibrosis." | 7.71 | Exhaled carbon monoxide is not elevated in patients with asthma or cystic fibrosis. ( Alving, K; Ihre, E; Johannesson, M; Lundberg, JO; Marteus, H; Nordval, SL; Zetterquist, W, 2002) |
| "Ethane levels were elevated in patients not on steroids (n = 13, 1." | 5.31 | Exhaled ethane is elevated in cystic fibrosis and correlates with carbon monoxide levels and airway obstruction. ( Barnes, PJ; Cramer, D; Hodson, ME; Kharitonov, SA; Leak, D; Paredi, P; Shah, PL, 2000) |
| "We evaluated the intra-session and inter-session variability of the diffusing capacity of nitric oxide (DLNO), carbon monoxide (DLCO), alveolar-capillary membrane diffusing capacity for carbon monoxide (DMCO) and pulmonary capillary blood volume (Vc) in patients with cystic fibrosis (CF)." | 5.24 | Intra-session and inter-session variability of nitric oxide pulmonary diffusing capacity in adults with cystic fibrosis. ( Benden, C; Dressel, H; Kriemler, S; Maggi-Beba, M; Radtke, T; van der Lee, I, 2017) |
| "Oxidative stress and hypoxia, which may occur in cystic fibrosis patients (CF) at rest and may be worsened by exercise, induce the expression of heme oxygenase (HO)-1, resulting in increased carbon monoxide (CO) formation." | 5.09 | Exhaled carbon monoxide concentration increases after exercise in children with cystic fibrosis. ( Apor, P; Borka, P; Horváth, I; Kollai, M, 1999) |
| "To estimate the value of diffusing capacity for carbon monoxide (T(LCO)) in patients with cystic fibrosis and to evaluate its ability to predict arterial desaturation during exercise." | 3.72 | [Diffusing capacity for carbon monoxide (T(LCO)) and oxygen saturation during exercise in patients with cystic fibrosis]. ( Belleguic, C; Chemery, L; Dabadie, A; Dassonville, J; Deneuville, E; Desrues, B; Fekete, K; Guillot, S; Roussey, M, 2004) |
| "Exhaled nitric oxide (eNO) and carbon monoxide (eCO) concentrations are elevated in inflammatory airway diseases like asthma and have been investigated as potential diagnostic markers." | 3.72 | Exhaled carbon monoxide is not flow dependent in children with cystic fibrosis and asthma. ( Beck-Ripp, J; Griese, M; Latzin, P, 2004) |
| "Increased levels of exhaled carbon monoxide (fractional concentration of CO in expired gas (FE,CO)), measured with an electrochemical sensor, have been reported in patients with inflammatory airway disorders, such as asthma, rhinitis and cystic fibrosis." | 3.71 | Exhaled carbon monoxide is not elevated in patients with asthma or cystic fibrosis. ( Alving, K; Ihre, E; Johannesson, M; Lundberg, JO; Marteus, H; Nordval, SL; Zetterquist, W, 2002) |
| "To explain why the single-breath carbon monoxide diffusing capacity (Dsb) was, on the average, elevated in 163 asthmatic subjects and 175 patients with cystic fibrosis, we simulated this elevation in ten normal subjects by having them perform the test for Dsb through an inspiratory obstruction." | 3.66 | Evaluation of the single-breath diffusing capacity in asthma and cystic fibrosis. ( Bryan, AC; Hyland, RH; Keens, TG; Krastins, IR; Levison, H; Mansell, A; Zamel, N, 1979) |
| "Lung inflammation is a pivotal phenomenon in the pathogenesis of cystic fibrosis." | 2.44 | [Measurement of pulmonary inflammation in cystic fibrosis]. ( Abely, M; Chiron, R; Fayon, M, 2008) |
| "These results suggest that there are differences in lung diffusion and peripheral SaO(2) according to genetic variation of the ADRB2 at position 27 which could play a potential role in dosing options or adjustments that may be required according to genotype." | 1.37 | Influence of genetic variation of the β2-adrenergic receptor on lung diffusion in patients with cystic fibrosis. ( Daines, CL; Foxx-Lupo, WT; Morgan, WJ; Patanwala, AE; Phan, H; Skrentny, TT; Snyder, EM; Sprissler, R; Traylor, BR; Wheatley, CM, 2011) |
| "Cystic fibrosis is characterised by oxidative stress in the airways." | 1.31 | Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis. ( Barnes, PJ; Ciabattoni, G; Corradi, M; Geddes, DM; Hodson, ME; Kharitonov, SA; Montuschi, P; van Rensen, L, 2000) |
| "Ethane levels were elevated in patients not on steroids (n = 13, 1." | 1.31 | Exhaled ethane is elevated in cystic fibrosis and correlates with carbon monoxide levels and airway obstruction. ( Barnes, PJ; Cramer, D; Hodson, ME; Kharitonov, SA; Leak, D; Paredi, P; Shah, PL, 2000) |
| "The most important results were a respiratory acidosis after intubation and simultaneous hyperoxigenation during controlled (manual) ventilation." | 1.28 | [Laboratory diagnostic monitoring of blood gas parameters in children during bronchologic studies]. ( Augst, D; Ballke, EH; Maass, B; Wiersbitzky, S; Zöllner, H, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (22.86) | 18.7374 |
| 1990's | 4 (11.43) | 18.2507 |
| 2000's | 15 (42.86) | 29.6817 |
| 2010's | 7 (20.00) | 24.3611 |
| 2020's | 1 (2.86) | 2.80 |
| Authors | Studies |
|---|---|
| Wardyn, PM | 1 |
| de Broucker, V | 1 |
| Chenivesse, C | 1 |
| Sobaszek, A | 1 |
| Van Bulck, R | 1 |
| Perez, T | 1 |
| Edmé, JL | 1 |
| Hulo, S | 1 |
| Radtke, T | 1 |
| Benden, C | 1 |
| Maggi-Beba, M | 1 |
| Kriemler, S | 1 |
| van der Lee, I | 1 |
| Dressel, H | 3 |
| Ryter, SW | 1 |
| Choi, AM | 1 |
| Fitzgerald, NM | 1 |
| Kennedy, B | 1 |
| Fitzgerald, DA | 1 |
| Selvadurai, H | 1 |
| Fayon, M | 1 |
| Chiron, R | 1 |
| Abely, M | 1 |
| Hubert, D | 1 |
| Aubourg, F | 1 |
| Fauroux, B | 1 |
| Trinquart, L | 1 |
| Sermet, I | 1 |
| Lenoir, G | 1 |
| Clément, A | 1 |
| Dinh-Xuan, AT | 1 |
| Louis, B | 1 |
| Mahut, B | 1 |
| Delclaux, C | 1 |
| Filser, L | 2 |
| Fischer, R | 2 |
| Marten, K | 1 |
| Müller-Lisse, U | 1 |
| de la Motte, D | 2 |
| Nowak, D | 2 |
| Huber, RM | 2 |
| Jörres, RA | 2 |
| Wheatley, CM | 3 |
| Foxx-Lupo, WT | 3 |
| Cassuto, NA | 1 |
| Wong, EC | 2 |
| Daines, CL | 2 |
| Morgan, WJ | 3 |
| Snyder, EM | 3 |
| Traylor, BR | 1 |
| Skrentny, TT | 1 |
| Phan, H | 1 |
| Patanwala, AE | 1 |
| Sprissler, R | 2 |
| Baker, SE | 1 |
| Martinez, MG | 1 |
| Morgan, MA | 1 |
| Zhou, M | 1 |
| Liu, Y | 1 |
| Duan, Y | 1 |
| Zetterquist, W | 1 |
| Marteus, H | 1 |
| Johannesson, M | 1 |
| Nordval, SL | 1 |
| Ihre, E | 1 |
| Lundberg, JO | 1 |
| Alving, K | 2 |
| Paredi, P | 3 |
| Kharitonov, SA | 5 |
| Barnes, PJ | 5 |
| Espiritu, JD | 1 |
| Ruppel, G | 1 |
| Shrestha, Y | 1 |
| Kleinhenz, ME | 1 |
| Terheggen-Lagro, SW | 1 |
| Bink, MW | 1 |
| Vreman, HJ | 1 |
| van der Ent, CK | 1 |
| DEMUTH, GR | 1 |
| HOWATT, WF | 1 |
| HILL, BM | 1 |
| WOOLF, CR | 1 |
| Merkus, PJ | 1 |
| Govaere, ES | 1 |
| Hop, WH | 1 |
| Stam, H | 1 |
| Tiddens, HA | 1 |
| de Jongste, JC | 2 |
| Chemery, L | 1 |
| Fekete, K | 1 |
| Guillot, S | 1 |
| Roussey, M | 1 |
| Desrues, B | 1 |
| Dabadie, A | 1 |
| Belleguic, C | 1 |
| Deneuville, E | 1 |
| Dassonville, J | 1 |
| Beck-Ripp, J | 1 |
| Latzin, P | 1 |
| Griese, M | 1 |
| Steinhaeusser, W | 1 |
| Graham, BL | 1 |
| Mink, JT | 1 |
| Cotton, DJ | 1 |
| Russell, NJ | 1 |
| Bagg, LR | 1 |
| Hughes, DT | 1 |
| Neville, E | 1 |
| O'Brodovich, HM | 1 |
| Mellins, RB | 1 |
| Mansell, AL | 1 |
| Shah, PL | 2 |
| Montuschi, P | 2 |
| Sullivan, P | 1 |
| Hodson, ME | 4 |
| Antuni, JD | 1 |
| Hughes, D | 1 |
| Ciabattoni, G | 1 |
| Corradi, M | 1 |
| van Rensen, L | 1 |
| Geddes, DM | 1 |
| Leak, D | 1 |
| Cramer, D | 1 |
| Horváth, I | 1 |
| Borka, P | 1 |
| Apor, P | 1 |
| Kollai, M | 1 |
| Keens, TG | 1 |
| Mansell, A | 1 |
| Krastins, IR | 1 |
| Levison, H | 2 |
| Bryan, AC | 1 |
| Hyland, RH | 1 |
| Zamel, N | 1 |
| Corbet, A | 1 |
| Ross, J | 1 |
| Popkin, J | 1 |
| Beaudry, P | 1 |
| Friedrich, U | 1 |
| Schuster, J | 1 |
| Zimmermann, T | 1 |
| Zöllner, H | 1 |
| Wiersbitzky, S | 1 |
| Ballke, EH | 1 |
| Augst, D | 1 |
| Maass, B | 1 |
| Featherby, EA | 1 |
| Weng, TR | 1 |
| Crozier, DN | 1 |
| Duic, A | 1 |
| Reilly, BJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Modifying Genes in Cystic Fibrosis: The Beta-2 Adrenergic Receptors and Epithelial Na+ Channels[NCT01880723] | 32 participants (Actual) | Interventional | 2009-05-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Using the rebreathe technique the diffusion capacity of the lungs for carbon monoxide and nitric oxide were measured, and this allowed for the determination of alveolar-capillary membrane conductance and pulmonary capillary blood volume. These measurements were made at baseline and 30-, 60- and 90-minutes post albuterol administration in cystic fibrosis and healthy subjects. (NCT01880723)
Timeframe: baseline, 30-, 60- and 90-minutes post albuterol administration
| Intervention | mL/min/mmHg (Mean) | |||
|---|---|---|---|---|
| Baseline | 30 minutes post | 60 minutes post | 90 minutes post | |
| Cystic Fibrosis | 17.3 | 17.4 | 17.0 | 17.1 |
| Healthy | 21.5 | 21.6 | 21.6 | 21.2 |
Using the rebreathe technique the diffusion capacity of the lungs for carbon monoxide and nitric oxide were measured, and this allowed for the determination of alveolar-capillary membrane conductance and pulmonary capillary blood volume. These measurements were made at baseline and 30-, 60- and 90-minutes post albuterol administration in cystic fibrosis and healthy subjects. (NCT01880723)
Timeframe: baseline, 30-, 60- and 90-minutes post albuterol administration
| Intervention | mL/min/mmHg (Mean) | |||
|---|---|---|---|---|
| Baseline | 30 minutes post | 60 minutes post | 90 minutes post | |
| Cystic Fibrosis | 55.0 | 56.4 | 56.2 | 58.5 |
| Healthy | 70.3 | 70.8 | 72.1 | 73.0 |
We collected exhaled breath condensate (EBC) samples, with subjects breathing on a Jaeger EcoScreen for 20 minutes. EBC samples were collected in cystic fibrosis and healthy subjects before and 30-, 60-, and 90-minutes following albuterol administration. (NCT01880723)
Timeframe: up to 90-minutes post albuterol
| Intervention | mmol/L (Mean) | |||
|---|---|---|---|---|
| Baseline | 30 minutes post | 60 minutes post | 90 minutes post | |
| Cystic Fibrosis | 2.24 | 2.11 | 1.73 | 1.86 |
| Healthy | 2.58 | 1.97 | 2.37 | 2.23 |
"The calculation of net chloride efflux was used to account for the paracellular reabsorption of Cl- that will follow the reabsorption of Na+ to maintain electroneutral ion flux. Thus, the net chloride efflux calculation used was the gross chloride concentration plus the absolute value of the percent change in sodium from baseline multiplied by the gross chloride concentration for each time point:~Net Cl- efflux - [Cl- X-min post] + (([Na+ X-min post]-[Na+Baseline])/ [Na+Baseline]) x [Cl- X-min post])" (NCT01880723)
Timeframe: baseline to 90 minutes post albuterol administration
| Intervention | mmol/L (Mean) | |||
|---|---|---|---|---|
| Baseline | 30 minutes post | 60 minutes post | 90 minutes post | |
| Cystic Fibrosis | 0.037 | 0.048 | 0.057 | 0.050 |
| Healthy | 0.064 | 0.078 | 0.084 | 0.077 |
A finger pulse oximeter allowed for the measurement of peripheral oxygen saturation at baseline, 30-, 60- and 90-minutes post albuterol in cystic fibrosis and healthy subjects. (NCT01880723)
Timeframe: baseline, 30-, 60- and 90-minutes post albuterol
| Intervention | percent of oxygenated hemoglobin (Mean) | |||
|---|---|---|---|---|
| Baseline | 30 minutes post | 60 minutes post | 90 minutes post | |
| Cystic Fibrosis | 98 | 98 | 98 | 99 |
| Healthy | 99 | 100 | 99 | 99 |
5 reviews available for carbon monoxide and Cystic Fibrosis
| Article | Year |
|---|---|
Carbon monoxide in exhaled breath testing and therapeutics.
Topics: Acute Lung Injury; Anesthesia; Animals; Asthma; Biomarkers; Breath Tests; Carbon Monoxide; Cystic Fi | 2013 |
[Measurement of pulmonary inflammation in cystic fibrosis].
Topics: Adult; Age Factors; Antioxidants; Biopsy; Breath Tests; Bronchi; Bronchoalveolar Lavage; Carbon Mono | 2008 |
Breath biomarkers in diagnosis of pulmonary diseases.
Topics: Asthma; Biomarkers; Breath Tests; Carbon Monoxide; Cystic Fibrosis; Humans; Hydrogen Peroxide; Lung | 2012 |
Analysis of expired air for oxidation products.
Topics: Asthma; Biomarkers; Breath Tests; Carbon Monoxide; Cystic Fibrosis; Humans; Hydrocarbons; Lipid Pero | 2002 |
Gas analysis.
Topics: Adult; Age Factors; Asthma; Biomarkers; Breath Tests; Carbon Monoxide; Child; Cystic Fibrosis; Elect | 2000 |
2 trials available for carbon monoxide and Cystic Fibrosis
| Article | Year |
|---|---|
Intra-session and inter-session variability of nitric oxide pulmonary diffusing capacity in adults with cystic fibrosis.
Topics: Carbon Monoxide; Cross-Over Studies; Cystic Fibrosis; Female; Humans; Male; Nitric Oxide; Pulmonary | 2017 |
Exhaled carbon monoxide concentration increases after exercise in children with cystic fibrosis.
Topics: Adolescent; Blood Pressure; Carbon Monoxide; Child; Cystic Fibrosis; Exercise; Exercise Test; Female | 1999 |
28 other studies available for carbon monoxide and Cystic Fibrosis
| Article | Year |
|---|---|
Assessing the applicability of the new Global Lung Function Initiative reference values for the diffusing capacity of the lung for carbon monoxide in a large population set.
Topics: Adult; Aged; Asthma; Bronchitis; Carbon Monoxide; Cystic Fibrosis; Female; Humans; Lung; Lung Diseas | 2021 |
Diffusion capacity of carbon monoxide (DLCO) pre- and post-exercise in children in health and disease.
Topics: Adolescent; Athletes; Breath Tests; Carbon Monoxide; Case-Control Studies; Child; Cystic Fibrosis; E | 2014 |
Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments.
Topics: Adolescent; Adult; Body Mass Index; Carbon Monoxide; Child; Cystic Fibrosis; Exercise Test; Exhalati | 2009 |
Lung diffusing capacity for nitric oxide and carbon monoxide in relation to morphological changes as assessed by computed tomography in patients with cystic fibrosis.
Topics: Adult; Carbon Monoxide; Cross-Sectional Studies; Cystic Fibrosis; Humans; Lung; Middle Aged; Nitric | 2009 |
Impaired lung diffusing capacity for nitric oxide and alveolar-capillary membrane conductance results in oxygen desaturation during exercise in patients with cystic fibrosis.
Topics: Adolescent; Adult; Blood-Air Barrier; Carbon Monoxide; Cystic Fibrosis; Exercise Test; Female; Human | 2011 |
Influence of genetic variation of the β2-adrenergic receptor on lung diffusion in patients with cystic fibrosis.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-2 Receptor Agonists; Adult; Albuterol; Carbo | 2011 |
Genetic variation of SCNN1A influences lung diffusing capacity in cystic fibrosis.
Topics: Adolescent; Adult; Alleles; Arizona; Carbon Monoxide; Cystic Fibrosis; Epithelial Sodium Channels; E | 2012 |
Exhaled carbon monoxide is not elevated in patients with asthma or cystic fibrosis.
Topics: Adolescent; Adult; Asthma; Breath Tests; Bronchodilator Agents; Carbon Monoxide; Chemical Fractionat | 2002 |
The diffusing capacity in adult cystic fibrosis.
Topics: Adult; Carbon Monoxide; Cystic Fibrosis; Female; Forced Expiratory Volume; Humans; Male; Plethysmogr | 2003 |
End-tidal carbon monoxide corrected for lung volume is elevated in patients with cystic fibrosis.
Topics: Adolescent; Adult; Breath Tests; Carbon Monoxide; Child; Cystic Fibrosis; Diffusion; Female; Forced | 2003 |
THE GROWTH OF LUNG FUNCTION.
Topics: Adolescent; Biometry; Body Constitution; Body Weight; Carbon Monoxide; Child; Cystic Fibrosis; Facto | 1965 |
THE RELATIONSHIPS BETWEEN MINUTE VENTILATION, PULMONARY GAS DIFFUSION AND RESPIRATORY WORK MEASURED SIMULTANEOUSLY DURING A STANDARD EXERCISE TEST.
Topics: Bronchial Diseases; Bronchiectasis; Bronchitis; Carbon Monoxide; Cystic Fibrosis; Eosinophilic Granu | 1965 |
Preserved diffusion capacity in children with cystic fibrosis.
Topics: Adolescent; Carbon Monoxide; Child; Cross-Sectional Studies; Cystic Fibrosis; Female; Humans; Longit | 2004 |
[Diffusing capacity for carbon monoxide (T(LCO)) and oxygen saturation during exercise in patients with cystic fibrosis].
Topics: Adolescent; Adult; Carbon Monoxide; Child; Cystic Fibrosis; Exercise; Female; Humans; Male; Oxygen; | 2004 |
Exhaled carbon monoxide is not flow dependent in children with cystic fibrosis and asthma.
Topics: Adolescent; Age Factors; Asthma; Biomarkers; Breath Tests; Carbon Monoxide; Child; Cystic Fibrosis; | 2004 |
Lung diffusing capacity for nitric oxide and carbon monoxide: dependence on breath-hold time.
Topics: Administration, Inhalation; Adult; Airway Obstruction; Breath Tests; Carbon Monoxide; Cystic Fibrosi | 2008 |
Overestimation of the single-breath carbon monoxide diffusing capacity in patients with air-flow obstruction.
Topics: Adolescent; Adult; Asthma; Carbon Monoxide; Cystic Fibrosis; Emphysema; Female; Humans; Lung Disease | 1984 |
Lung function in young adults with cystic fibrosis.
Topics: Adolescent; Adult; Carbon Monoxide; Cystic Fibrosis; Female; Humans; Lung; Male; Pulmonary Diffusing | 1982 |
Effects of growth on the diffusion constant for carbon monoxide.
Topics: Adolescent; Adult; Age Factors; Body Height; Carbon Monoxide; Child; Cystic Fibrosis; Female; Humans | 1982 |
Increased carbon monoxide in exhaled air of patients with cystic fibrosis.
Topics: Adrenal Cortex Hormones; Adult; Breath Tests; Carbon Monoxide; Cystic Fibrosis; Female; Humans; Infl | 1999 |
Increase in exhaled carbon monoxide during exacerbations of cystic fibrosis.
Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Biomarkers; Breath Tests; Carbon Monoxide; Cr | 2000 |
Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis.
Topics: Adult; Biomarkers; Breath Tests; Carbon Monoxide; Cystic Fibrosis; Dinoprost; F2-Isoprostanes; Force | 2000 |
Exhaled ethane is elevated in cystic fibrosis and correlates with carbon monoxide levels and airway obstruction.
Topics: Adult; Carbon Monoxide; Case-Control Studies; Cystic Fibrosis; Ethane; Female; Humans; Lipid Peroxid | 2000 |
Evaluation of the single-breath diffusing capacity in asthma and cystic fibrosis.
Topics: Adolescent; Adult; Airway Obstruction; Asthma; Bronchodilator Agents; Carbon Monoxide; Child; Cystic | 1979 |
Relationship of arterial-alveolar nitrogen tension to alveolar-arterial oxygen tension, lung volume, flow measurements, and diffusing capacity in cystic fibrosis.
Topics: Adolescent; Carbon Dioxide; Carbon Monoxide; Child; Child, Preschool; Cystic Fibrosis; Female; Human | 1975 |
[Pulmonary transfer factor for carbon monoxide (TLco) in healthy children and in children with chronic lung diseases, measured with an improved rebreathing technique].
Topics: Asthma; Carbon Monoxide; Child; Cystic Fibrosis; Humans; Pulmonary Diffusing Capacity; Respiratory F | 1990 |
[Laboratory diagnostic monitoring of blood gas parameters in children during bronchologic studies].
Topics: Acid-Base Equilibrium; Acidosis, Respiratory; Anesthesia, General; Anesthesia, Inhalation; Asthma; B | 1990 |
Dynamic and static lung volumes, blood gas tensions, and diffusing capacity in patients with cystic fibrosis.
Topics: Adolescent; Adult; Airway Resistance; Carbon Dioxide; Carbon Monoxide; Child; Cystic Fibrosis; Diffu | 1970 |